Compare LNTH & INGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LNTH | INGR |
|---|---|---|
| Founded | 1956 | 1906 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.5B | 7.2B |
| IPO Year | 2014 | 1997 |
| Metric | LNTH | INGR |
|---|---|---|
| Price | $103.83 | $101.36 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 7 |
| Target Price | $87.00 | ★ $128.57 |
| AVG Volume (30 Days) | ★ 898.9K | 744.6K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 2.94% |
| EPS Growth | N/A | ★ 15.14 |
| EPS | 1.80 | ★ 2.22 |
| Revenue | $343,374,000.00 | ★ $7,219,000,000.00 |
| Revenue This Year | N/A | $3.86 |
| Revenue Next Year | $14.19 | $2.95 |
| P/E Ratio | $57.96 | ★ $45.45 |
| Revenue Growth | ★ 3.62 | N/A |
| 52 Week Low | $47.27 | $97.12 |
| 52 Week High | $104.50 | $140.02 |
| Indicator | LNTH | INGR |
|---|---|---|
| Relative Strength Index (RSI) | 68.01 | 41.69 |
| Support Level | $93.33 | $99.50 |
| Resistance Level | N/A | $115.56 |
| Average True Range (ATR) | 3.52 | 2.47 |
| MACD | -0.00 | 0.35 |
| Stochastic Oscillator | 92.79 | 51.24 |
Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.
Ingredion is an ingredients provider for the food, beverage, brewing, and animal nutrition industries. The company processes corn, tapioca, potatoes, stevia, grains, fruits, gums, and vegetables into value-added ingredients. The company sells specialty ingredients that include starch-based texturizers and natural alternative sweeteners such as stevia. Ingredion also sells commodity ingredients that include sweeteners, such as high-fructose corn syrup, and starches, such as those used for sustainable packaging, as well as plant-based proteins.